Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Givinostat Hydrochloride Patent Expiration

Givinostat Hydrochloride was first introduced by Italfarmaco Spa in its drug Duvyzat on Mar 21, 2024.


Givinostat Hydrochloride Patents

Given below is the list of patents protecting Givinostat Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Duvyzat US10688047 Physically and chemically stable oral suspensions of givinostat Oct 28, 2036 Italfarmaco Spa
Duvyzat US7329689 Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester Jan 15, 2025 Italfarmaco Spa
Duvyzat US9421184 Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy Feb 03, 2032 Italfarmaco Spa
Duvyzat US9867799 Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy Feb 03, 2032 Italfarmaco Spa


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳